ViewRay Valuation
| VRAYDelisted Stock | USD 0.04 0 5.67% |
ViewRay seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of ViewRay from inspecting the company fundamentals such as Shares Outstanding of 183.4 M, operating margin of (1.02) %, and Return On Equity of -1.09 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ViewRay's price fluctuation is very steady at this time. Calculation of the real value of ViewRay is based on 3 months time horizon. Increasing ViewRay's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ViewRay is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ViewRay Stock. However, ViewRay's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0416 | Real 0.0395 | Hype 0.04 |
The intrinsic value of ViewRay's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ViewRay's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ViewRay helps investors to forecast how ViewRay stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ViewRay more accurately as focusing exclusively on ViewRay's fundamentals will not take into account other important factors: ViewRay Total Value Analysis
ViewRay is at this time forecasted to have valuation of 11.47 M with market capitalization of 4.59 M, debt of 86.4 M, and cash on hands of 157.59 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ViewRay fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.47 M | 4.59 M | 86.4 M | 157.59 M |
ViewRay Investor Information
About 17.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.26. ViewRay had not issued any dividends in recent years. The entity had 683:576 split on the 8th of July 2015. Based on the key measurements obtained from ViewRay's financial statements, ViewRay is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.ViewRay Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ViewRay has an asset utilization ratio of 37.66 percent. This suggests that the Company is making $0.38 for each dollar of assets. An increasing asset utilization means that ViewRay is more efficient with each dollar of assets it utilizes for everyday operations.ViewRay Ownership Allocation
ViewRay shows a total of 183.4 Million outstanding shares. The majority of ViewRay outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in ViewRay to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in ViewRay. Please pay attention to any change in the institutional holdings of ViewRay as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.ViewRay Profitability Analysis
The company reported the previous year's revenue of 102.21 M. Net Loss for the year was (107.33 M) with profit before overhead, payroll, taxes, and interest of 10.04 M.About ViewRay Valuation
Our relative valuation model uses a comparative analysis of ViewRay. We calculate exposure to ViewRay's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ViewRay's related companies.ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Viewray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 267 people.
ViewRay Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 180.7 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |